SEEING CLEARLY & BEING SEEN
Vision. Choices. A Voice in Your Care.
###
TUESDAY, OCTOBER 20, 2026
4–6 PM PT | 7–9 PM ET
Virtual • Global • Two 1-Hour Sessions • Medical & Patient Panels • Q&A • 30-Minute Afterparty
###
SESSION 1
WHEN ONE BECOMES TWO
Understanding Double Vision in Thyroid Eye Disease
Double vision can be one of the most disruptive effects of TED — affecting driving, reading, working, walking safely, and everyday independence. Why does it happen? How does it change over the course of TED? And what can be done?
Two people living with TED-related double vision join two strabismus specialists for a candid conversation about the real-life impact of seeing two, why TED causes the eyes to become misaligned, and the options for managing and treating double vision — from patches and prisms to surgical correction.
PANEL
Alejandra De Alba Campomanes, MD, MPH, Specializing in strabismus (abnormal eye alignment) at at the University of California, San Francisco
Brent Hayek, MD, Oculoplastic and reconstructive surgeon at North Georgia Eye Associates
Joe LoVerde, TED Patient
Chesna Adams, TED Patient
Facilitated by Carol Bowden, PharmD, MBA, BCPS
TED/Graves’ patient, pharmacist & healthcare professional
###
SESSION 2
WHICH TREATMENT IS RIGHT FOR ME?
Understanding Today’s TED Treatment Choices
There are more ways to treat TED today — and more decisions for patients to make. How do treatments differ? What are the potential benefits, risks, and side effects? And how do you and your medical team determine which approach may be appropriate for you?
A multidisciplinary panel of leading TED specialists explores today’s treatment landscape –from established approaches to newer therapies and surgery — and the factors that can guide individual treatment decisions. Most importantly, we’ll talk about how your symptoms, health history, priorities, concerns, and goals can become part of shared decision-making.
PANEL
Bryan J. Winn, MD is a Professor of Ophthalmology and an oculoplastic and orbital surgeon at the University of California, San Francisco.
Dr. Margarita R. Ochoa-Maya, Endocrinologist, Chief Medical Advisor THYROSCOPE INC.
Don O. Kikkawa, MD, University of California, San Diego, Chief, Division of Oculofacial Plastic and Reconstructive Surgery.
Shoaib Ugradar, MD, is a board‑certified oculoplastic and orbital surgeon specializing in eyelid, orbital, and thyroid eye disease (TED).
Facilitated by Christine Gustafson
Founder & CEO, TED Community Organization
YOUR QUESTIONS. OUR CONVERSATION.
What do you want our experts to answer?
When you register, you’ll have an opportunity to submit your questions for our medical and patient panels. The final 10 minutes of each session will be devoted to audience Q&A, bringing your questions directly into the conversation.
Q&A Moderated by Stephen Marmaras
Director, Thyroid Eye Disease (TED) Advocacy Relations
Amgen Rare Disease
###
30-Minute Afterparty ~ Everyone Welcome
Each session will include dedicated time for audience questions, followed by an optional 30-minute virtual afterparty where participants can continue the conversation, connect with others in the TED community, and share their experiences in a welcoming and supportive environment.
###
Whether you are newly diagnosed, actively seeking treatment, living in recovery, caring for a loved one, or supporting patients professionally, we invite you to join us for an evening of learning, connection, and hope.
Together, we are rewriting our story. Reclaiming our lives.
Thank you for supporting our innovative educational work on behalf of all those affected by thyroid eye disease!
A special thanks to Leapcure for hosting the platform for CONNECTED 2026.
TED Community Organization
We Educate
We Support
We Connect
All those affected by Thyroid Eye Disease (TED)
You’ll never walk alone.
